Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propranolol for Renal Angiomyolipomas in Tuberous Sclerosis
NCT02104011Phase 2Terminated
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of propranolol in renal angiomyolipoma (AML), sponsored by Centre Hospitalier Universitaire de Bordeaux. Started May 2015; status: terminated.
02
Drugs
propranolol
03
Conditions
renal angiomyolipoma (AML)
Beyond the preview
Go deeper on NCT02104011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104011.